MCM10
Basic information
Region (hg38): 10:13161558-13211110
Links
Phenotypes
GenCC
Source:
- immunodeficiency 80 with or without congenital cardiomyopathy (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Immunodeficiency 80 with or without congenital cardiomyopathy | AR | Allergy/Immunology/Infectious; Cardiovascular | Individuals are susceptible to severe infections, and early and aggressive management may be beneficial related to morbidity and mortality; BMT has been described; Individuals have been described with cardiomyopathy, and early diagnosis may allow management | Allergy/Immunology/Infectious; Cardiovascular | 32865517; 33712616 |
ClinVar
This is a list of variants' phenotypes submitted to
- Immunodeficiency 80 with or without congenital cardiomyopathy (2 variants)
- Fetal Cardiomyopathy (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MCM10 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 8 | |||||
missense | 38 | 48 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 2 | 1 | 4 | ||
non coding | 11 | 11 | ||||
Total | 1 | 0 | 38 | 11 | 18 |
Highest pathogenic variant AF is 0.00000657
Variants in MCM10
This is a list of pathogenic ClinVar variants found in the MCM10 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-13164233-A-T | not specified | Benign (Jan 24, 2024) | ||
10-13170884-C-T | not specified | Benign (Jan 24, 2024) | ||
10-13170915-C-A | Benign (Apr 10, 2018) | |||
10-13170981-G-A | not specified | Uncertain significance (May 05, 2023) | ||
10-13171015-G-A | not specified | Likely benign (Jul 14, 2023) | ||
10-13171022-T-C | Likely benign (Aug 01, 2024) | |||
10-13171088-G-C | not specified | Uncertain significance (Jun 29, 2023) | ||
10-13171119-G-A | not specified | Uncertain significance (Aug 14, 2023) | ||
10-13171148-TG-T | Immunodeficiency 80 with or without congenital cardiomyopathy • Fetal Cardiomyopathy | Pathogenic (Mar 23, 2023) | ||
10-13171200-A-G | not specified | Likely benign (Jan 16, 2024) | ||
10-13171215-C-T | not specified | Uncertain significance (Aug 04, 2023) | ||
10-13171227-G-A | not specified | Uncertain significance (Nov 21, 2023) | ||
10-13171243-A-G | not specified | Uncertain significance (Nov 07, 2023) | ||
10-13171247-G-A | not specified | Likely benign (Aug 01, 2024) | ||
10-13172436-C-T | not specified | Uncertain significance (Apr 07, 2022) | ||
10-13172640-G-A | not specified | Uncertain significance (Jun 28, 2023) | ||
10-13172762-C-G | not specified | Likely benign (Apr 08, 2024) | ||
10-13172812-A-G | not specified | Benign (Jan 24, 2024) | ||
10-13175515-A-G | not specified | Uncertain significance (Aug 01, 2022) | ||
10-13175587-G-T | not specified | Uncertain significance (Jun 23, 2021) | ||
10-13175592-A-G | not specified | Likely benign (Aug 28, 2023) | ||
10-13175623-A-G | not specified | Uncertain significance (Sep 14, 2022) | ||
10-13175630-G-A | not specified | Uncertain significance (Apr 08, 2024) | ||
10-13175636-C-T | Likely benign (Apr 01, 2022) | |||
10-13175652-T-G | not specified | Uncertain significance (Dec 09, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MCM10 | protein_coding | protein_coding | ENST00000484800 | 19 | 49551 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.38e-15 | 0.977 | 125679 | 0 | 69 | 125748 | 0.000274 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.167 | 496 | 486 | 1.02 | 0.0000280 | 5674 |
Missense in Polyphen | 150 | 138.79 | 1.0808 | 1657 | ||
Synonymous | 0.731 | 171 | 184 | 0.931 | 0.0000111 | 1672 |
Loss of Function | 2.48 | 31 | 49.9 | 0.621 | 0.00000269 | 602 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000695 | 0.000693 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000550 | 0.000544 |
Finnish | 0.000326 | 0.000323 |
European (Non-Finnish) | 0.000230 | 0.000229 |
Middle Eastern | 0.000550 | 0.000544 |
South Asian | 0.000262 | 0.000261 |
Other | 0.000337 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as a replication initiation factor that brings together the MCM2-7 helicase and the DNA polymerase alpha/primase complex in order to initiate DNA replication. Additionally, plays a role in preventing DNA damage during replication. Key effector of the RBBP6 and ZBTB38-mediated regulation of DNA-replication and common fragile sites stability; acts as a direct target of transcriptional repression by ZBTB38 (PubMed:24726359). {ECO:0000269|PubMed:11095689, ECO:0000269|PubMed:15136575, ECO:0000269|PubMed:17699597, ECO:0000269|PubMed:19608746, ECO:0000269|PubMed:24726359}.;
- Pathway
- Cell Cycle;DNA Replication;Activation of ATR in response to replication stress;G2/M Checkpoints;Cell Cycle Checkpoints;Activation of the pre-replicative complex;Mitotic G1-G1/S phases;DNA Replication;G1/S Transition;DNA Replication Pre-Initiation;M/G1 Transition;Cell Cycle;Cell Cycle, Mitotic
(Consensus)
Recessive Scores
- pRec
- 0.137
Intolerance Scores
- loftool
- 0.937
- rvis_EVS
- -0.03
- rvis_percentile_EVS
- 50.54
Haploinsufficiency Scores
- pHI
- 0.264
- hipred
- N
- hipred_score
- 0.277
- ghis
- 0.636
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.648
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mcm10
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; cellular phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- G1/S transition of mitotic cell cycle;DNA replication;DNA replication initiation;cellular response to DNA damage stimulus;cell population proliferation
- Cellular component
- nucleus;nucleoplasm;nucleolus;replication fork protection complex
- Molecular function
- DNA replication origin binding;double-stranded DNA binding;single-stranded DNA binding;protein binding;enzyme binding;identical protein binding;metal ion binding